219Three-dimensional printing as a cutting-edge, versatile and personalizable vascular stent manufacturing procedure: Toward tailor-made medical devices.

Autor:	Garcia-Villen F; NanoBioCel Group, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006, Vitoria-Gasteiz, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 01006, Vitoria-Gasteiz, Spain.; Bioaraba, NanoBioCel Research Group, 01009, Vitoria-Gasteiz, Spain., López-Zárraga F; Department of Vascular and Interventional Radiology, Álava University Hospital, Integrated Health Organization of Álava (Osakidetza), Spain., Viseras C; Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada (UGR), Campus of Cartuja, 18071 s/n, Granada, Spain.; Andalusian Institute of Earth Sciences, CSIC-University of Granada, Avda. de Las Palmeras 4, 18100, Armilla, Granada, Spain., Ruiz-Alonso S; NanoBioCel Group, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006, Vitoria-Gasteiz, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 01006, Vitoria-Gasteiz, Spain.; Bioaraba, NanoBioCel Research Group, 01009, Vitoria-Gasteiz, Spain., Al-Hakim F; NanoBioCel Group, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006, Vitoria-Gasteiz, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 01006, Vitoria-Gasteiz, Spain.; Bioaraba, NanoBioCel Research Group, 01009, Vitoria-Gasteiz, Spain., Diez-Aldama I; NanoBioCel Group, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006, Vitoria-Gasteiz, Spain., Saenz-Del-Burgo L; NanoBioCel Group, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006, Vitoria-Gasteiz, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 01006, Vitoria-Gasteiz, Spain.; Bioaraba, NanoBioCel Research Group, 01009, Vitoria-Gasteiz, Spain., Scaini D; Joint Research Laboratory (JRL). School of Pharmacy, University of the Basque Country (UPV/ EHU), 01006, Vitoria-Gasteiz, Spain., Pedraz JL; NanoBioCel Group, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006, Vitoria-Gasteiz, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 01006, Vitoria-Gasteiz, Spain.; Bioaraba, NanoBioCel Research Group, 01009, Vitoria-Gasteiz, Spain.
Jazyk:	angličtina
Zdroj:	International journal of bioprinting [Int J Bioprint] 2023 Jan 09; Vol. 9 (2), pp. 664. Date of Electronic Publication: 2023 Jan 09 (Print Publication: 2023).
DOI:	10.18063/ijb.v9i2.664
Abstrakt:	Vascular stents (VS) have revolutionized the treatment of cardiovascular diseases, as evidenced by the fact that the implantation of VS in coronary artery disease (CAD) patients has become a routine, easily approachable surgical intervention for the treatment of stenosed blood vessels. Despite the evolution of VS throughout the years, more efficient approaches are still required to address the medical and scientific challenges, especially when it comes to peripheral artery disease (PAD). In this regard, three-dimensional (3D) printing is envisaged as a promising alternative to upgrade VS by optimizing the shape, dimensions and stent backbone (crucial for optimal mechanical properties), making them customizable for each patient and each stenosed lesion. Moreover, the combination of 3D printing with other methods could also upgrade the final device. This review focuses on the most recent studies using 3D printing techniques to produce VS, both by itself and in combination with other techniques. The final aim is to provide an overview of the possibilities and limitations of 3D printing in the manufacturing of VS. Furthermore, the current situation of CAD and PAD pathologies is also addressed, thus highlighting the main weaknesses of the already existing VS and identifying research gaps, possible market niches and future directions. Competing Interests: The authors declare no conflicts of interests. (Copyright: © 2023, Garcia-Villen, et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu